• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Gelatin, Soft Capsule Gelatin, Hard Capsule Gelatin, Pharmaceutical Gelatin-Foodmate
Neohesperidin
Advantame
Cleanroom Bench Horizontal Laminar Flow Hood Airflow Clean Bench
Pharma and Food Grade, USP/FCC Neotame Sweetener E961
Trilobatin

US FDA completes inspection of Lupin’s Pithampur Unit-2 (Indore) facility

expressbpdFebruary 12, 2019

Tag: lupin , Inspection , FDA

US FDA completes inspection of Lupin’s Pithampur Unit-2 (Indore) facility.

US FDA completes inspection of Lupin’s Pithampur Unit-2 (Indore) facility

Lupin announced the completion of the United States Food and Drug Administration (US FDA) inspection carried out at its Pithampur Unit -2 (Indore) facility. The inspection was carried out between January 14 and January 25, 2019.

The inspection at Pithampur Unit-2 (Indore) closed with six observations. The company is confident ofaddressing the observations satisfactorily.

Register as Visitor to CPhI China 2019!

Register as Visitor to CPhI China 2019!

-----------------------------------------------------------------------
Editor's Note:

To apply for becoming a contributor of En-CPhI.cn,

welcome to send your CV and sample works to us,

Email: Julia.Zhang@ubmsinoexpo.com.

 

Previous:Aurobindo acquires Apotex’s operations in five European countries

Next:WuXi Biologics and Amicus Sign Exclusive Manufacturing Partnership

Related News

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Everest Medicines LimitedDecember 20, 2024

Everest Medicines announced NMPA acceptance of NDA for VELSIPITY(R) (etrasimod) to treat moderately to severely active UC.

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

PRNewswireDecember 12, 2024

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

PRNewswireDecember 12, 2024

US FDA completes inspection of Lupin’s Pithampur Unit-2 (Indore) facility | Pharmasources.com

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

PRNewswireDecember 12, 2024

Core8 Group, an Australian leader in high-tech and biotech innovation, has unveiled plans to develop Vietnam's first AI x ESG Hospital, marking a significant milestone in healthcare transformation.

You may like
More>>

Bleomycin sulfate (FDA)

Bleomycin sulfate (FDA)
Fosphenytoin sodium (FDA)

Fosphenytoin sodium (FDA)
Two-side Tablet Inspection Machine Model YJ-25T

Two-side Tablet Inspection Machine Model YJ-25T
Auto Filled Capsule Inspection Machine Model CI5F

Auto Filled Capsule Inspection Machine Model CI5F
Tacrolimus (FDA)

Tacrolimus (FDA)
JAZ800/5 Automatic Ampoule Impurity Inspection Machine

JAZ800/5 Automatic Ampoule Impurity Inspection Machine
Light inspection machine

Light inspection machine
JSSZ/300 Plastic Infusion Bottle Impurity Automatic Inspection Machine

JSSZ/300 Plastic Infusion Bottle Impurity Automatic Inspection Machine
Vitamine B12 (FDA)

Vitamine B12 (FDA)
Inspection Machine Model KJ-150 for Oral Solution

Inspection Machine Model KJ-150 for Oral Solution

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service